期刊文献+

可溶性血管内皮生长因子受体1在IgA肾病中的临床意义 被引量:2

Clinical significance of soluble fms-like tyrosine kinase-1 in IgA nephropathy
下载PDF
导出
摘要 目的 探讨可溶性血管内皮生长因子受体1 (soluble fms-like tyrosine kinase-1,sFlt-1)在IgA肾病中表达变化的临床意义与病理类型之间的关系.方法 选取2005年1月至2013年3月期间内蒙古自治区医院经肾活检确诊为IgA肾病的80例患者作为病例组,选30名健康献血者作为对照组,测定两组所有人员血浆中sFlt-1表达水平.将80例病例组患者按IgA肾病病理表现分为新月体形成组(36例)及硬化肾小球组(20例),另有24例IgA肾病患者同时存在新月体形成及硬化肾小球,对比sFlt-1在新月体形成组和硬化肾小球组的相关性.结果 病例组血浆sFlt-1明显高于对照组(P<0.01);病例组中新月体形成组的患者血浆中sFlt-1含量明显升高,硬化肾小球组患者血浆中sFlt-1含量相对偏低,sFlt-1与新月体比例呈正相关,而与硬化肾小球比例不相关.结论 检测sFlt-1在IgA肾病中有重要的临床意义,sFlt-1与IgA肾病病理类型有相关性. Objective Study clinical significance in the changes of soluble fins-like tyrosine ki- nase-1 expression of IgA nephropathy and its related links with pathology phenotpes of IgA nephropa- thy. Vascular Endothelial Growth Factor Receptor Methods Select 80 patients with IgA nephropathY of kidney biopsy-confirmed during the January 2005-march 2013 in Inner Mongolia Autonomous Re- gion hospital as a group of cases, selected 30 healthy blood donors as the control group. Detecting the plasma levels of soluble fins-like tyrosine kinase-1 in the IgA nephropathy group and the control group;Divide the IgA patients into two groups: one group with crescent formation and the other group with sclerosis glomerulus, and compare detecting the plasma levels of soluble fins-like tyrosine kinase- 1 ng the correlation of the soluble fins-like tyrosine kinase-1. Apply SPSS 13.0 statistical software for statistical analysis. Results The plasma levels of sFlt-1 in IgA group was significantly higher than the normal control group (P^0. 01), the levels of sFlt-1 group of IgA nephropathy patients with crescent formation are significantly higher, but are lower in IgAN patients with sclerotic glomeruli, levels of sFlt-1 are positively correlated with crescent ratio, but are not correlated with sclerotic glomeruli ratio. Conclusions Detecting the plasma levels of soluble fins-like tyrosine kinase-1 has a important clinical significance, sFlt-1 and IgA nephropathy has correlation.
出处 《临床肾脏病杂志》 2014年第2期97-100,共4页 Journal Of Clinical Nephrology
关键词 IGA肾病 可溶性血管内皮生长因子受体1 病理类型 IgA nephropathy sFlt-1 Pathological type
  • 相关文献

参考文献18

  • 1邹玉蓉,张萍,李贵森,廖常志,张杰.不同IgA肾病病理评分方法的临床适用性评估[J].四川医学,2009,30(4):470-472. 被引量:1
  • 2Marco GS, Reter S, Hillebrand U, et al. The soluble VEGF re- ceptor sFlt-1 contributes to endothelial dysfunction in CKD. J Am Soc Nehrol, 2009,20 : 2235-2245.
  • 3宋荣,周琼,乔福元,刘海意.重度子痫前期患者脐静脉血清中VEGF及sFlt-1的表达及其对内皮细胞损伤的影响[J].华中科技大学学报(医学版),2010,39(5):691-694. 被引量:11
  • 4Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Ensl J Med,2004,350: 672-683.
  • 5Maynard,Jiang-Yong Min, Jaime Merchan, etal. Excess pla- cental soluble fins-like tyrosine kinase 1 may contribute to en- dothelial dysfunction, hypertension, and proteinuria in pre- eclampsia. J Clin Invest, 2003,111 : 649-658.
  • 6Rollins B J, Walz B J, BaggionlinirrL Recombnanthuman MCP- 1/JE induces chemotaxis, calciumflux, and the respiratory burst in human monocytes. Blood, 1991,7 : 1112-1116.
  • 7Purpura KA, George SH, Dang SM. Solule Fit-1 regulates FLK-1 activation to control he-matopoietic and endothelial de- velopment in an oxygen-responsive manner. Stem Cells, 2008, 2611:2832-2842.
  • 8范青锋,邢燕,丁洁,管娜.血管内皮生长因子表达降低导致多柔比星肾病大鼠蛋白尿发生[J].实用儿科临床杂志,2008,23(17):1326-1329. 被引量:3
  • 9Rne AM, Bouchier-Hayes DJ. Angiogenic and cell survival functions of vascular endothelial growth factor. J Cell Mol Med, 2005,9 : 777-794.
  • 10hibuya M, Claesson-Welsh. Signal transduction by VEGF recdptors in regulation of angiogenesis and lymph angiogene- sis. Exp Cell Res,2006,312:549-560.

二级参考文献60

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2邢燕,丁洁,范青锋,管娜.足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿[J].中华肾脏病杂志,2006,22(1):27-32. 被引量:39
  • 3邢燕,丁洁,范青锋,管娜,张敬京.三种不同药物作用下足细胞分子的变化[J].中华肾脏病杂志,2006,22(5):275-281. 被引量:12
  • 4蒋镭,吕继成,陈文芳,王素霞,邹万忠,刘刚,张宏,王海燕.IgA肾病简明半定量病理评分方法及其与预后的关系[J].中华肾脏病杂志,2007,23(5):278-282. 被引量:40
  • 5Lee SM, Rao VM, Franklin WA, et al. IgA, nePhroPathy: morPhologic Preclictors of Progressive renal disease[J].Hum Pathol, 1982, 13(4):314-322
  • 6Hass M. Histologic subclassification of IgA nePhroPathy:a clincialpathological study of 244 cases[J].Am J Kidney Dis,1997,29(6) :829- 842
  • 7Austin HA 3rd, Muenz LR, Joyce KM, et al. Diffuse Proliferavive lupus nephritis: idnetification of specific Pathologic features affecting renal outcome[J]. KJidney Int, 1984,25(4) :689 - 695
  • 8Hotta O, Funata T, Chiba S, et al. Regression of IgA nePhroPathy: a rePeat bioPsy study[J]. Am J Kidney Dis,2002,39(3) :493 - 502
  • 9Kuriki M, Asahi K, Asano K, et al. Steroid therapy reduces mesangial matrix accumulation in advanced IgA nePhroPathy [ J ]. NePhrol Dial TransPlant,2003,18(7) : 1311 - 1315
  • 10Fioretto P, Sutherland DE, Najafian B, et al. Remodeling of renal intersitial and tubular lesions in Pancreas transplant reciPients[J]. Kidney Int,2006,69(3):907-912

共引文献34

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部